Please assess the completion status of the following clinical trial:

Trial Title: Accommodative Relief for Uncomfortable Non-Presbyopes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Visual acuity of 20/25 or better in both eyes with habitual contact lenses~* -0.75 D or more myopic in both eyes~* -0.75 D or less astigmatism in both eyes~* Current single vision contact lens wearer who does not require a reading aid~* CLDEQ-8 score of 12 or more points with habitual contact lenses~* No history of ocular surgery or medication~* Reports digital device use of at least 3 hours per day~* No significant signs of dry eye (grade 1 or less ocular surface staining, Schirmer score of 7 mm or more, and tear break up time of 7 seconds or more in bother eyes)~* No significant binocular vision disorders in both eyes (eso or exophoria of 4 prism diopters or less at distance and near, near point of convergence of 6 mm or less, no history of strabismus or patching)

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Single Vision First (Type: EXPERIMENTAL): Subjects in this group will receive the single vision spherical (Bausch + Lomb ULTRA®) lens for the first two weeks and be crossed over to the multifocal (Bausch + Lomb ULTRA® for Presbyopia) lens for the second two weeks.Therefore, this group will receive both study interventions.
- Multifocal first (Type: EXPERIMENTAL): Subjects in this group will receive the multifocal (Bausch + Lomb ULTRA® for Presbyopia) lenses for the first two weeks and be crossed over to the single vision spherical (Bausch + Lomb ULTRA®) lens for the second two weeks. Therefore, this group will receive both study interventions.

Based on this trial design, predict the completion outcome and termination type (if applicable).